AU2007287353A8 - Method for improving pharmacokinetics - Google Patents

Method for improving pharmacokinetics

Info

Publication number
AU2007287353A8
AU2007287353A8 AU2007287353A AU2007287353A AU2007287353A8 AU 2007287353 A8 AU2007287353 A8 AU 2007287353A8 AU 2007287353 A AU2007287353 A AU 2007287353A AU 2007287353 A AU2007287353 A AU 2007287353A AU 2007287353 A8 AU2007287353 A8 AU 2007287353A8
Authority
AU
Australia
Prior art keywords
improving pharmacokinetics
pharmacokinetics
improving
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2007287353A
Other versions
AU2007287353A1 (en
Inventor
Michael Ge
Chandra J. Panchal
Jinzi J. Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ambrilia Biopharma Inc
Original Assignee
Ambrilia Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ambrilia Biopharma Inc filed Critical Ambrilia Biopharma Inc
Publication of AU2007287353A1 publication Critical patent/AU2007287353A1/en
Publication of AU2007287353A8 publication Critical patent/AU2007287353A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
AU2007287353A 2006-07-17 2007-07-16 Method for improving pharmacokinetics Abandoned AU2007287353A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US83120906P 2006-07-17 2006-07-17
US60/831,209 2006-07-17
PCT/IB2007/003593 WO2008023273A2 (en) 2006-07-17 2007-07-16 Method for improving pharmacokinetics

Publications (2)

Publication Number Publication Date
AU2007287353A1 AU2007287353A1 (en) 2008-02-28
AU2007287353A8 true AU2007287353A8 (en) 2009-02-26

Family

ID=39107180

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007287353A Abandoned AU2007287353A1 (en) 2006-07-17 2007-07-16 Method for improving pharmacokinetics

Country Status (5)

Country Link
EP (1) EP2109461A2 (en)
JP (1) JP2010502569A (en)
AU (1) AU2007287353A1 (en)
CA (1) CA2657316A1 (en)
WO (1) WO2008023273A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8227450B2 (en) 2005-11-30 2012-07-24 Ambrilia Biopharma Inc. Lysine-based prodrugs of aspartyl protease inhibitors and processes for their preparation
US8410300B2 (en) * 2006-09-21 2013-04-02 Taimed Biologics, Inc. Protease inhibitors
WO2009148600A2 (en) * 2008-06-06 2009-12-10 Concert Pharmaceuticals, Inc. Deuterated lysine-based compounds
EP2435037B1 (en) 2009-05-27 2014-11-12 Merck Sharp & Dohme Corp. Hiv protease inhibitors
EP2632895B1 (en) 2010-10-28 2018-10-03 Merck Canada Inc. Hiv protease inhibitors
US9187415B2 (en) 2010-10-29 2015-11-17 Merck Canada Inc. Sulfonamides as HIV protease inhibitors
EP2771332B1 (en) 2011-10-26 2016-06-29 Merck Canada Inc. Thiophen and thiazol sulfonamid derivatives as HIV protease inhibitors for the treatment of AIDS
WO2017209732A1 (en) * 2016-05-31 2017-12-07 Taimed Biologics, Inc. A long acting pharmaceutical composition of protease inhibitor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632816B1 (en) * 2002-12-23 2003-10-14 Pharmacor Inc. Aromatic derivatives as HIV aspartyl protease inhibitors
ES2575871T3 (en) * 2004-08-02 2016-07-01 Ambrilia Biopharma Inc. Pharmaceutical compositions comprising a lysine-based compound and an HIV antiviral or antiretroviral agent
US7388008B2 (en) * 2004-08-02 2008-06-17 Ambrilia Biopharma Inc. Lysine based compounds
US20060287316A1 (en) * 2005-04-27 2006-12-21 Ambrilia Biopharma Inc. Method for improving pharmacokinetics of protease inhibitors and protease inhibitor precursors
US8227450B2 (en) * 2005-11-30 2012-07-24 Ambrilia Biopharma Inc. Lysine-based prodrugs of aspartyl protease inhibitors and processes for their preparation

Also Published As

Publication number Publication date
AU2007287353A1 (en) 2008-02-28
WO2008023273A3 (en) 2011-03-03
JP2010502569A (en) 2010-01-28
EP2109461A2 (en) 2009-10-21
CA2657316A1 (en) 2008-02-28
WO2008023273A2 (en) 2008-02-28
WO2008023273A8 (en) 2008-06-05

Similar Documents

Publication Publication Date Title
EP1811339B8 (en) Pattern forming method
EP1991365B8 (en) Methods for forming silver-nanoparticle treated surfaces
AU2007287353A8 (en) Method for improving pharmacokinetics
EP2224797A4 (en) Method for forming elecroconductive thin line
EP2114996B8 (en) Method for preparing hypoallergens
WO2010010360A9 (en) Method
EP2048490B8 (en) Method for estimating reflectance
WO2008070467A8 (en) Method for preventing chronic disease
AU2006903509A0 (en) Improved method
AU2006900509A0 (en) Method
AU2006903158A0 (en) Method for Agglomeration
AU2006903508A0 (en) Improved Process
AU2006907206A0 (en) Anti-tagging profiling method parameters
AU2006900719A0 (en) Process
AU2007900306A0 (en) Improved Method
AU2007900288A0 (en) Improved Method
AU2006902078A0 (en) Improvent for two-stroke-engines
AU2007905494A0 (en) Dermaportation Method
AU2009297631B2 (en) Method for manufacturing hyper-coal
AU2006906553A0 (en) Indexing method
AU2006906152A0 (en) Information Indendification Method
AU2006900568A0 (en) A method
AU2006901400A0 (en) A method
AU2006906425A0 (en) Chromatography method
AU2006903157A0 (en) Improved Leaching Method

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 23, NO 5, PAGE(S) 6581 UNDER THE HEADING PCT APPLICATIONS THAT HAVE ENTERED THE NATIONAL PHASE - NAME INDEX UNDER THE NAME AMBRILIA BIOPHARMA INC., APPLICATION NO. 2007287353, UNDER INID (72) CORRECT THE CO-INVENTOR NAME TO READ PANCHAL, CHANDRA J.

MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period